title: Influence of adjuvant anastrozole on bone mineral density in Japanese postmenopausal breast cancer patients: is there a racial difference?
authors.forename: K
authors.initials: K
authors.lastname: Yoneda
authors.forename: Y
authors.initials: Y
authors.lastname: Tanji
authors.forename: M
authors.initials: M
authors.lastname: Okishiro
authors.forename: T
authors.initials: T
authors.lastname: Taguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Tamaki
authors.forename: S
authors.initials: S
authors.lastname: Noguchi
mesh_terms: D000368:Aged; D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D044466:Asian People; D015415:Biomarkers / Q000378:metabolism; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000208:ethnology; D017024:Chemotherapy, Adjuvant; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D007564:Japan; D008875:Middle Aged; D009570:Nitriles / Q000494:pharmacology* / Q000627:therapeutic use; D017698:Postmenopause; D014230:Triazoles / Q000494:pharmacology* / Q000627:therapeutic use; D044465:White People
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015415:Biomarkers; D004967:Estrogens; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole